These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25315987)

  • 1. Liver disease after hematopoietic cell transplantation in adults.
    Norvell JP
    Transplant Rev (Orlando); 2015 Jan; 29(1):8-15. PubMed ID: 25315987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.
    Abdelbary H; Magdy R; Moussa M; Abdelmoaty I
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):11. PubMed ID: 32372257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic approach to hepatic complications in hematopoietic stem cell transplantation.
    Arai S; Lee LA; Vogelsang GB
    J Hematother Stem Cell Res; 2002 Apr; 11(2):215-29. PubMed ID: 11983095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature.
    Padmanabhan S; Battiwalla M; Hahn T; Ball D; Paplham P; Brown K; Segal BH; McCarthy P; Almyroudis NG
    Transpl Infect Dis; 2007 Jun; 9(2):148-52. PubMed ID: 17462002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver complications in stem-cell transplantation].
    Karthaus M; Meier PN; Manns MP; Ganser A; Hertenstein B
    Dtsch Med Wochenschr; 1997 Sep; 122(38):1154-60. PubMed ID: 9378027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatobiliary complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
    Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2020 Jan; 107(1S):S18-S27. PubMed ID: 30952358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors.
    Yoshimura K; Kimura SI; Kawamura M; Kawamura S; Takeshita J; Yoshino N; Misaki Y; Gomyo A; Matsumi S; Akahoshi Y; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Sato M; Terasako-Saito K; Tanihara A; Nakasone H; Kako S; Kanda Y
    Int J Hematol; 2021 Dec; 114(6):674-681. PubMed ID: 34378178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose.
    Stueck AE; Fiel MI
    Hum Pathol; 2023 Nov; 141():170-182. PubMed ID: 37541449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients].
    Kikuchi T; Mori T; Koda Y; Saburi M; Kohashi S; Toyama T; Kato J; Hashimoto S; Nakatsuka M; Ebinuma H; Okamoto S
    Rinsho Ketsueki; 2014 Nov; 55(11):2320-3. PubMed ID: 25501415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic complications of hematopoietic cell transplantation.
    Levitsky J; Sorrell MF
    Curr Gastroenterol Rep; 2007 Mar; 9(1):60-5. PubMed ID: 17335679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung.
    Kambham N; Higgins JP; Sundram U; Troxell ML
    Adv Anat Pathol; 2014 Sep; 21(5):301-20. PubMed ID: 25105933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
    Hidaka M; Iwasaki S; Matsui T; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Kiyokawa T; Takahashi M; Saibara T; Onishi S; Kawano F
    Bone Marrow Transplant; 2010 May; 45(5):912-8. PubMed ID: 19802024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
    Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
    Park M; Koh KN; Kim BE; Im HJ; Seo JJ
    Clin Transplant; 2011; 25(2):E168-76. PubMed ID: 21077955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the toxicity of hematopoietic stem cell transplant.
    Pallera AM; Schwartzberg LS
    J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
    Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
    Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.